AccueilBoutiqueInjectableRipped 250 – Royal Pharmaceuticals

Ripped 250 – Royal Pharmaceuticals

Ripped 250 by Royal Pharmaceuticals is a 250 mg/ml research-only injectable blend containing Testosterone Propionate (100 mg), Drostanolone Propionate (50 mg) and Trenbolone Acetate (50 mg). Designed for intramuscular depot studies, this short-ester AAS combination is used in research exploring androgen signalling, nitrogen retention, erythropoiesis and metabolic effects. Not for human or veterinary use.

 69.00

Gagner 6.9 CandyCoins
Ajouter à la liste de souhaits Ajouter à la comparaison
Catégorie : Marque :

CandyGym Fitness

Description

Ripped 250 – Royal Pharmaceuticals (Research-Grade AAS Blend)

Catégorie : Injectable Anabolic-Androgenic Steroid Blend (Research Only)
Marque : Royal Pharmaceuticals
Strength: 250 mg/ml total (Test P 100 mg, Mast P 50 mg, Tren A 50 mg)
Packing: 10 × 1 ml ampoules
Origin: United Kingdom
Prix : €69
Use Notice: For laboratory and analytical research only — not for human or veterinary administration.


🧪 What is Ripped 250?

Ripped 250 is a fixed-combination injectable consisting of three short-acting anabolic–androgenic steroid esters:

  • Testosterone Propionate – 100 mg
  • Drostanolone Propionate (Masteron P) – 50 mg
  • Trenbolone Acetate – 50 mg

Short-chain esters create rapid release from the intramuscular depot, making this blend suitable for research requiring frequent sampling intervals or tight control of androgen exposure.


🔬 Key Technical Characteristics

  • Pharmacological class: Anabolic-androgenic steroids (AAS)
  • Route: Intramuscular injection
  • Ester types: Propionate (Test/Mast) and acetate (Tren)
  • Approximate half-lives: Test P ~2 days, Mast P ~2 days, Tren A ~2–3 days
  • WADA status: All components are prohibited at all times under “Anabolic Agents”.

🧬 Mechanism of Action

Testosterone Propionate

  • Esterified form of endogenous testosterone
  • Promotes protein synthesis, nitrogen retention and erythropoiesis
  • Aromatises to estradiol and converts to DHT

Drostanolone Propionate (Masteron P)

  • DHT-derived androgen with no aromatisation
  • Strong AR binding; low water-retention profile
  • May exhibit mild anti-estrogenic action at receptor level

Trenbolone Acetate

  • 19-nor testosterone derivative with extremely high AR affinity
  • Does not aromatise; interacts with progesterone receptors
  • Associated with strong anabolic effects and reduced glucocorticoid signalling

Together, these compounds produce additive or synergistic effects on androgen-mediated pathways while also accumulating their individual risk profiles.


📚 Research Overview

  • Testosterone esters — studied extensively in hypogonadism, lean-mass changes, bone density and hematology.
  • Drostanolone — historically investigated in hormone-responsive breast cancer; displays typical DHT-like androgenic behaviour.
  • Trenbolone — widely documented in veterinary models; shows powerful anabolic, neuroendocrine, and metabolic effects.

Ripped 250 as a combined formulation lacks clinical trial data; research is based on extrapolation from individual components.


📈 Potential Research-Level Observations

  • Enhanced protein synthesis and nitrogen retention
  • Marked changes in red blood cell mass and hemoglobin
  • Reduced fat mass and altered nutrient partitioning (trenbolone-related)
  • Increased muscle density and tissue “hardness” in controlled models

These findings apply only to research settings and do not imply suitability for unsupervised use.


⚠️ Risk Profile & Possible Adverse Effects

Endocrine & Reproductive

  • Suppression of LH/FSH and endogenous testosterone
  • Testicular atrophy, reduced sperm count, infertility
  • Virilisation and menstrual disruption in females

Cardiovascular & Metabolic

  • Reduced HDL, increased LDL
  • Hypertension, fluid retention (via testosterone)
  • Increased risk of thrombotic or cardiovascular events
  • Polycythaemia (elevated hematocrit)

Hepatic & Renal

  • Potential hepatic strain despite being non-oral injectables
  • Renal stress secondary to blood-pressure alteration

Neuropsychiatric

  • Mood instability, irritability, anxiety
  • Insomnia or reduced impulse control

Other

  • Acne, seborrhoea, androgenic alopecia
  • Injection-site pain or infection
  • Gynecomastia risk due to testosterone aromatisation combined with trenbolone’s progestogenic action

🛑 Compliance & Regulatory Notice

  • All three ingredients are controlled/prescription-only substances in many jurisdictions.
  • WADA prohibits testosterone, drostanolone and trenbolone in- and out-of-competition.
  • Analytical detection windows vary depending on dose and duration.
  • This product is supplied strictly for laboratory and analytical research — not for therapeutic or recreational use.

📊 Technical Data Table

Parameter Test P Mast P Tren A
Chemical class Androgen / AAS DHT-derived AAS 19-nor AAS
Concentration (mg/ml) 100 mg 50 mg 50 mg
Ester Propionate Propionate Acetate
Aromatisation Yes No No (progestogenic)
Demi-vie ~2 days ~2 days ~2–3 days
Main receptor AR, aromatase (indirect) Androgen receptor AR & progesterone receptors
WADA status Prohibited Prohibited Prohibited

For laboratory research only — not for human or veterinary use.

Rated 5 out of 5
Basé sur les commentaires de 0
0
0
0
0
0

Il n'y a pas encore de commentaires.

×
Votre panier
Le panier est vide.
Remplissez votre panier avec des articles étonnants
Acheter
 0.00
Les frais d'expédition et les taxes peuvent être recalculés au moment du paiement.
 0.00